Skip to main content
OpenTrials
Completed

NCT Number: NCT04410497

Silver Foam Dressing Superior to Porcine Xenograft in Pediatric Scalds

Prospective randomized trial where two dressings has been compared for partial thickness scald burns in children 6 months to 6 years.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

6 month–6 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Burn Centre at Linköping University Hospital,

Linköping, 58185, Sweden

About this study

Aim: The aim of this study was to compare two different treatment regimes for children with partial-thickness scald burns. Burns were treated with either a porcine xenograft (EZderm®, Mölnlycke Health Care, Gothenburg, Sweden) or a silver foam dressing (Mepilex® Ag, Mölnlycke Health Care, Gothenburg, Sweden).

Methods: A prospective randomized clinical trial including 58 children admitted between May 2015 and May 2018 for partial-thickness scalds to The Burn Centre in Linkoping, Sweden. Primary outcome was time to wound closure. Secondary outcomes were pain, need of surgery, wound infection, length of hospital stay, required dressings changes, and labour time.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Partial-thickness scald burns admitted within 72 hours of injury and with burns suitable for porcine xenograft according to the burn surgeon on duty were eligible and enrolled after (guardians) consenting to participate.

Exclusion criteria

  • Children with other severe concomitant cutaneous trauma, skin disease, or children with a known hypersensitivity to silver.

Treatment and study plan

Porcine xenograft (wound dressings)

Other

commercial porcine xenograft, derived from acellular dermis from porcine.

Other names: EZderm from Mölnlycke Healthcare AB, Gothenburg, Sweden

Silver foam (wound dressings)

Other

commercial silver containing foam dressing

Other names: Mepilex Ag from Mölnlycke Healthcare AB, Gothenburg, Sweden

Primary outcomes

  1. Time to complete wound closure

    Time frame: Evaluated 2-3 times per week until complete wound closure, approximatley 15-20 days after injury (injury-complete healing)

    Calculated from the date of injury to the date when the wound bed was assessed as completely reepithelialized with no necessity for further wound dressings other than a protective dressing against shearing, according to both the attending physician and nurse

Secondary outcomes

  1. Pain (at wound site)

    Time frame: Evaluated before,during and after dressing changes, performed 2-3 times per week until complete wound closure, approximatley 15-20 days after injury.

    Pain is to evaluated by staff before, during and after wound dressing Changes using the Face, Legs, Activity, Cry, Consolability, behavioural pain scale (FLACC) is a five-category behavioral instrument where each category is scored on a scale of 0-2, resulting in a result between 0-10

  2. Need of surgery

    Time frame: Evaluated at dressing changes, performed 2-3 times per week until complete wound closure, approximatley 15-20 days after injury.

    Evaluated as yes or no (surgery perfomered according to the medical record)

  3. Burn wound infection

    Time frame: Evaluated at each dressing change; 2-3 times per week until complete wound closure, approximatley 15-20 days after injury.

    Children were diagnosed with burn wound infection by the burn surgeon and a consultant physician specialized in infectious diseases if fulfilling at least two of the following criteria based on American Burn Association definition of burn wound infection

    • Clinical signs such as localised pain and swelling, spreading erythema (redness), and heat at the affected site.
    • Surface wound swab culture presenting a minimum of 106 colony-forming units (CFU)/L (equivalent to the ABA definition of 105 CFU/g) [29].
    • Systemic signs of infection indicated as a rise of C-reactive protein (CRP) level (reference range < 10 mg/L for capillary sampling) together with increased body temperature exceeding 38 °C- 48 hours after injury where other sources of infection are excluded
  4. Length of hospital stay

    Time frame: Evaluated after complete wound closure, approximatley 15-20 days after injury.

    number of days when the child received in hospital care (including readmissions)

  5. number of dressing changes required

    Time frame: Evaluated at dressing changes, performed 2-3 times per week until complete wound closure, approximatley 15-20 days after injury.

    documented in CRF and in medical records

  6. adverse events

    Time frame: Evaluated at dressing changes, performed 2-3 times per week until complete wound closure, approximatley 15-20 days after injury.

    any local reaction seen in or around wound during the time when study dressings were used

  7. Minutes needed for application and removal of dressing

    Time frame: Evaluated at dressing changes, performed 2-3 times per week until complete wound closure, approximatley 15-20 days after injury.

    documented in CRF and in medical records

Sponsors and collaborators

Lead sponsor

University Hospital, Linkoeping

Other

Registry information

Official study title

Silver Foam Dressing Superior to Porcine Xenograft in Pediatric Scalds: A Prospective Randomized Controlled Trial

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Jun 1, 2020
Registry last updated
Jun 1, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.